Humana Inc. (NYSE:HUM) Stock Holdings Raised by Empowered Funds LLC

Empowered Funds LLC lifted its stake in shares of Humana Inc. (NYSE:HUM) by 164.0% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The fund owned 14,914 shares of the insurance provider’s stock after purchasing an additional 9,264 shares during the period. Empowered Funds LLC’s holdings in Humana were worth $4,724,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. Pzena Investment Management LLC raised its stake in Humana by 538.7% during the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock valued at $866,250,000 after buying an additional 1,955,375 shares in the last quarter. Marshall Wace LLP increased its holdings in shares of Humana by 118.9% in the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock valued at $532,564,000 after acquiring an additional 774,085 shares during the last quarter. International Assets Investment Management LLC raised its position in shares of Humana by 261,025.1% during the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock valued at $2,340,660,000 after acquiring an additional 738,701 shares in the last quarter. Steadfast Capital Management LP bought a new position in Humana during the first quarter worth $158,813,000. Finally, Baupost Group LLC MA acquired a new position in Humana in the second quarter worth $156,933,000. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of analysts have weighed in on HUM shares. Jefferies Financial Group cut shares of Humana from a “buy” rating to a “hold” rating and dropped their target price for the stock from $519.00 to $253.00 in a report on Monday, October 7th. Oppenheimer lowered their price objective on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a research report on Thursday, October 3rd. Sanford C. Bernstein raised shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 target price on the stock in a report on Tuesday, October 8th. JPMorgan Chase & Co. upped their target price on Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Finally, Deutsche Bank Aktiengesellschaft dropped their price target on Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Twenty analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Humana has a consensus rating of “Hold” and an average target price of $315.86.

Humana Stock Down 2.6 %

HUM stock opened at $275.67 on Monday. The firm’s 50-day moving average is $281.36 and its two-hundred day moving average is $331.94. The company has a market capitalization of $33.19 billion, a price-to-earnings ratio of 24.42, a price-to-earnings-growth ratio of 2.17 and a beta of 0.52. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $527.18. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. On average, analysts forecast that Humana Inc. will post 15.86 earnings per share for the current fiscal year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.28%. Humana’s dividend payout ratio (DPR) is 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.